REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

PT Meprofarm (Indonesia)

Main Activities: Medicinal and Botanical Manufacturing
Full name: PT Meprofarm Profile Updated: February 28, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

meprofarm pt is a pharmaceutical company that specializes in manufacturing medicines and operates two manufacturing facilities, MEPRO 1 and MEPRO 2. meprofarm pt is currently developing a new production facility, MEPRO 2, focused on producing various forms of liquid injection preparation, liquid syrup, cream, and suppositories/ovules. The company is open to cooperation with other pharmaceutical industries.

Headquarters
RT 003 RW 004
Bandung; West Java; Postal Code: 40294

Contact Details: Purchase the PT Meprofarm report to view the information.

Website: http://www.meprofarm.com

Basic Information
Total Employees:
Purchase the PT Meprofarm report to view the information.
Outstanding Shares:
Purchase the PT Meprofarm report to view the information.
Registered Capital:
Purchase the PT Meprofarm report to view the information.
Incorporation Date:
February 10, 1973
Key Executives
Purchase this report to view the information.
President Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after PT Meprofarm report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
5.04%▲
Total operating revenue
5.04%▲
Total assets
5.09%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo